Join THANZ and HSANZ for a webinar exploring recent developments in venous thromboembolism (VTE) management and laboratory practice.
This session will review the recently published COBRRA study, examining the comparative bleeding risk between rivaroxaban and apixaban, discuss updates from the latest VTE clinical guidelines, and explore the role of DOAC testing in the laboratory, including current applications and practical considerations for pathology professionals.
Hear from leading experts as they discuss the clinical implications of these developments and their impact on patient care and laboratory practice.
Featured Speakers
-
A/Prof Vivien Chen
-
Dr Dani Robinson
-
Dr Kirollos Kamel